Cargando…
Offering Financial Incentives to Increase Adherence to Antipsychotic Medication: The Clinician Experience
Financial incentives for medication adherence in patients with psychotic disorders are controversial. It is not yet known whether fears expressed by clinicians are borne out in reality. We aimed to explore community mental health clinicians’ experiences of the consequences of giving patients with ps...
Autores principales: | Highton-Williamson, Elizabeth, Barnicot, Kirsten, Kareem, Tarrannum, Priebe, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352071/ https://www.ncbi.nlm.nih.gov/pubmed/25692797 http://dx.doi.org/10.1097/JCP.0000000000000276 |
Ejemplares similares
-
Discontinuing financial incentives for adherence to antipsychotic depot medication: long-term outcomes of a cluster randomised controlled trial
por: Priebe, Stefan, et al.
Publicado: (2016) -
Acceptability of offering financial incentives to achieve medication adherence in patients with severe mental illness: a focus group study
por: Priebe, Stefan, et al.
Publicado: (2010) -
Effectiveness of financial incentives to improve adherence to maintenance treatment with antipsychotics: cluster randomised controlled trial
por: Priebe, Stefan, et al.
Publicado: (2013) -
Cost-Effectiveness of Financial Incentives to Promote Adherence to Depot Antipsychotic Medication: Economic Evaluation of a Cluster-Randomised Controlled Trial
por: Henderson, Catherine, et al.
Publicado: (2015) -
Ethical acceptability of offering financial incentives for taking antipsychotic depot medication: patients’ and clinicians’ perspectives after a 12-month randomized controlled trial
por: Noordraven, Ernst L., et al.
Publicado: (2017)